Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRESY
3426
Cresud
CRESY
$784M
| $2.12M | ﹤0.01% |
322,251
+151,381
| +89% | +$1.13M |
|
3427
CALL
NIO
NIO
$10.9B
| $2.11M | ﹤0.01% |
233,600
+98,700
| +73% | +$1.1M |
|
3428
CALL
Teva Pharmaceuticals
TEVA
$42.5B
| $2.11M | ﹤0.01% |
206,800
-175,000
| -46% | -$1.63M |
|
3429
CALL
Star Bulk Carriers
SBLK
$3.4B
| $2.11M | ﹤0.01% |
+109,400
| New | +$1.95M |
|
3430
JELD-WEN Holding
JELD
$220M
| $2.1M | ﹤0.01% |
157,303
+74,861
| +91% | +$1.17M |
|
3431
CALL
GE HealthCare
GEHC
$32.4B
| $2.1M | ﹤0.01% |
30,800
+19,800
| +180% | +$1.44M |
|
3432
PUT
NOV
NOV
$7.48B
| $2.09M | ﹤0.01% |
+100,000
| New | +$1.99M |
|
|
KEEL
3433
Keel Infrastructure Corp
KEEL
$1.99B
| $2.09M | ﹤0.01% |
1,947,165
+733,579
| +60% | +$1.07M |
|
|
UROY
3434
Uranium Royalty Corp
UROY
$1.62B
| $2.09M | ﹤0.01% |
727,536
+674,447
| +1,270% | +$1.59M |
|
|
TRHC
3435
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.09M | ﹤0.01% |
202,388
-4,161
| -2% | -$39.5K |
|
3436
Brink's
BCO
$4.57B
| $2.09M | ﹤0.01% |
28,718
-27,328
| -49% | -$1.97M |
|
3437
iShares MSCI Hong Kong ETF
EWH
$1.26B
| $2.08M | ﹤0.01% |
+121,567
| New | +$2.24M |
|
3438
Cohu
COHU
$2.27B
| $2.07M | ﹤0.01% |
60,112
-4,653
| -7% | -$175K |
|
3439
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.53B
| $2.07M | ﹤0.01% |
139,961
+74,090
| +112% | +$1.14M |
|
3440
ESCO Technologies
ESE
$7.18B
| $2.07M | ﹤0.01% |
19,800
-2,152
| -10% | -$221K |
|
3441
Hingham Institution for Saving
HIFS
$650M
| $2.07M | ﹤0.01% |
11,073
-14,890
| -57% | -$3.05M |
|
3442
Ally Financial
ALLY
$12.8B
| $2.07M | ﹤0.01% |
77,438
-1,878,509
| -96% | -$52.5M |
|
3443
MidCap Financial Investment
MFIC
$792M
| $2.07M | ﹤0.01% |
150,251
+7,010
| +5% | +$93.8K |
|
3444
CALL
Molina Healthcare
MOH
$10.4B
| $2.07M | ﹤0.01% |
+6,300
| New | +$1.98M |
|
|
RVPH
3445
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $2.06M | ﹤0.01% |
21,157
-1,827
| -8% | -$170K |
|
3446
Plexus
PLXS
$6.42B
| $2.06M | ﹤0.01% |
22,183
+4,498
| +25% | +$436K |
|
3447
PagSeguro Digital
PAGS
$2.45B
| $2.06M | ﹤0.01% |
239,466
+104,636
| +78% | +$985K |
|
3448
Teleflex
TFX
$5.92B
| $2.05M | ﹤0.01% |
10,417
-9,069
| -47% | -$2.06M |
|
3449
PUT
BioVie
BIVI
$18.3M
| $2.05M | ﹤0.01% |
+6,000
| New | +$2.35M |
|
3450
Global X Copper Miners ETF NEW
COPX
$8.64B
| $2.04M | ﹤0.01% |
56,124
-12,844
| -19% | -$490K |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.